KKR & Co Inc (KKR) has acquired a large stake in Henry Schein (HSIC) and plans to work with the medical- and dental-supply company to boost its operations, The Wall Street Journal reported Wednesday, citing unnamed people familiar with the matter.
The private equity firm plans to reveal an agreement that includes raising its stake in Henry Schein to 12% with an option to buy a further 2.9% in the future, the sources told WSJ.
Henry Schein has also agreed to give the KKR two board seats, with a representative from KKR joining a board committee that has been working on CEO succession planning, according to the report.
KKR and Henry Schein did not immediately respond to MT Newswires' request for comment on the matter.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。